Integra Lifesciences Holdings Corp
Research Integra Lifesciences Holdings Corp (IART) on Bullrun: market cap USD 1.31B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIART
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 1.31B
- Financial periodQ2 2026
- RevenueUSD 418.76M
- Net incomeUSD 4.48M
- Free cash flowUSD 10.50M
- Gross margin52.5%
Valuation Snapshot
latest market cap is USD 1.31B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.64B | -USD 516.80M | -USD 31.05M | 50.9% | -6.74 | USD 235.05M | USD 726.56M | USD 1.04B |
| FY2024 | USD 1.61B | -USD 6.90M | USD 24.96M | 54.8% | -0.09 | USD 246.38M | USD 760.47M | USD 1.55B |
| FY2023 | USD 1.54B | USD 67.70M | USD 73.09M | 57.4% | 0.84 | USD 276.40M | USD 775.00M | USD 1.59B |
| FY2022 | USD 1.56B | USD 180.60M | USD 222.13M | 62.3% | 2.16 | USD 456.66M | USD 775.00M | USD 1.80B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.31B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 967.36M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.75B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 3.40B | 35.7 | n/a | n/a |
| 2022 | 2022-12-30 | USD 4.68B | 27.4 | n/a | n/a |
| 2021 | 2021-12-31 | USD 5.67B | 33.8 | n/a | n/a |
About Integra Lifesciences Holdings Corp
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Integra Lifesciences Holdings Corp's market cap?
Integra Lifesciences Holdings Corp's market capitalization is USD 1.31B.
What does Integra Lifesciences Holdings Corp do?
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment.